S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:IDXX

IDEXX Laboratories Stock Competitors

$635.15
+5.43 (+0.86 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$631.76
$637.37
50-Day Range
$612.77
$688.33
52-Week Range
$416.48
$706.95
Volume262,006 shs
Average Volume406,423 shs
Market Capitalization$54.04 billion
P/E Ratio75.70
Dividend YieldN/A
Beta0.92

IDEXX Laboratories (NASDAQ:IDXX) Vs. ABT, MDT, ISRG, SYK, EW, BDX, BSX, DXCM, BAX, and RMD

Should you be buying IDEXX Laboratories stock or one of its competitors? The main competitors of IDEXX Laboratories include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, Dickinson and (BDX), Boston Scientific (BSX), DexCom (DXCM), Baxter International (BAX), and ResMed (RMD). These companies are all part of the "health care equipment" industry.

IDEXX Laboratories vs.

IDEXX Laboratories (NASDAQ:IDXX) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Medtronic received 1053 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. Likewise, 79.16% of users gave Medtronic an outperform vote while only 73.71% of users gave IDEXX Laboratories an outperform vote.

CompanyUnderperformOutperform
IDEXX LaboratoriesOutperform Votes
485
73.71%
Underperform Votes
173
26.29%
MedtronicOutperform Votes
1538
79.16%
Underperform Votes
405
20.84%

IDEXX Laboratories has a net margin of 23.89% compared to Medtronic's net margin of 12.29%. IDEXX Laboratories' return on equity of 115.28% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
IDEXX Laboratories 23.89% 115.28% 32.06%
Medtronic 12.29% 13.85% 7.49%

84.7% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 79.6% of Medtronic shares are owned by institutional investors. 2.1% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.5% of Medtronic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Medtronic had 14 more articles in the media than IDEXX Laboratories. MarketBeat recorded 19 mentions for Medtronic and 5 mentions for IDEXX Laboratories. Medtronic's average media sentiment score of 0.23 beat IDEXX Laboratories' score of -0.06 indicating that Medtronic is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IDEXX Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medtronic
2 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

IDEXX Laboratories has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500.

Medtronic has higher revenue and earnings than IDEXX Laboratories.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IDEXX Laboratories$2.71 billion19.96$581.78 million$6.7194.66
Medtronic$30.12 billion5.70$3.61 billionN/AN/A

IDEXX Laboratories currently has a consensus price target of $675.00, suggesting a potential upside of 6.27%. Medtronic has a consensus price target of $144.55, suggesting a potential upside of 13.15%. Given Medtronic's stronger consensus rating and higher probable upside, analysts clearly believe Medtronic is more favorable than IDEXX Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IDEXX Laboratories
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60
Medtronic
0 Sell rating(s)
5 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.80

Summary

Medtronic beats IDEXX Laboratories on 10 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IDEXX Laboratories (NASDAQ:IDXX) vs. Its Competitors

TypeIDEXX LaboratoriesDiagnostic substances IndustryMedical SectorNASDAQ Exchange
P/E Ratio75.7019.5328.7027.90
Net Margins23.89%-2,960.78%-3,875.95%-1,243.44%

IDEXX Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
3.095 of 5 stars
$117.49
+0.1%
$131.27
+11.7%
+9.5%$208.29B$34.61B33.10109,000Upcoming Earnings
Analyst Report
Analyst Revision
News Coverage
MDT
Medtronic
3.0967 of 5 stars
$127.75
+2.3%
$144.24
+12.9%
+18.8%$171.68B$30.12B44.6790,000Analyst Revision
ISRG
Intuitive Surgical
2.1764 of 5 stars
$331.50
+0.2%
$327.89
+1.1%
+34.2%$118.34B$4.36B24.788,081Upcoming Earnings
Short Interest ↑
SYK
Stryker
2.7822 of 5 stars
$266.32
+0.9%
$286.43
+7.6%
+19.8%$100.43B$14.35B48.782,020
EW
Edwards Lifesciences
2.2031 of 5 stars
$112.16
+0.5%
$118.44
+5.6%
+31.5%$69.91B$4.39B48.1414,900Insider Selling
News Coverage
BDX
Becton, Dickinson and
2.6309 of 5 stars
$241.16
+0.6%
$273.63
+13.5%
+2.6%$69.26B$17.12B37.8672,000
BSX
Boston Scientific
2.3004 of 5 stars
$43.40
+0.3%
$49.13
+13.2%
+11.3%$61.80B$9.91B131.522,020
DXCM
DexCom
2.3617 of 5 stars
$544.47
+1.8%
$516.93
+5.1%
+36.3%$52.68B$1.93B103.715,500Analyst Revision
BAX
Baxter International
2.8498 of 5 stars
$79.70
+0.2%
$91.18
+14.4%
-1.1%$39.84B$11.67B36.392,020News Coverage
RMD
ResMed
2.0598 of 5 stars
$255.49
+0.3%
$241.50
+5.5%
+42.3%$37.22B$3.20B78.857,770Insider Selling
STE
STERIS
2.4998 of 5 stars
$225.09
+0.4%
$242.40
+7.7%
+20.2%$22.45B$3.11B67.3913,000Analyst Revision
PODD
Insulet
2.0619 of 5 stars
$300.49
+1.2%
$283.50
+5.7%
+19.9%$20.70B$904.40M-653.241,900Analyst Revision
HOLX
Hologic
2.4623 of 5 stars
$69.67
+0.8%
$86.93
+24.8%
+5.7%$17.66B$3.78B8.935,814Analyst Report
Short Interest ↓
TFX
Teleflex
2.7998 of 5 stars
$363.20
+0.4%
$455.80
+25.5%
+0.4%$17.00B$2.54B49.0114,000News Coverage
ABMD
Abiomed
2.0064 of 5 stars
$351.37
+1.8%
$363.75
+3.5%
+23.9%$15.95B$847.52M104.571,725
MASI
Masimo
1.8898 of 5 stars
$286.12
+0.3%
$292.75
+2.3%
+22.9%$15.75B$1.14B74.125,300Analyst Report
HRC
Hill-Rom
2.3881 of 5 stars
$151.00
+0.6%
$141.80
+6.1%
+68.4%$9.94B$2.88B42.5410,000Short Interest ↑
GMED
Globus Medical
2.3492 of 5 stars
$76.43
+0.9%
$82.18
+7.5%
+38.5%$7.71B$789.04M42.462,200News Coverage
IART
Integra LifeSciences
1.9777 of 5 stars
$67.68
+0.7%
$75.75
+11.9%
+41.1%$5.72B$1.37B28.083,700
ATRC
AtriCure
2.0989 of 5 stars
$71.37
+0.0%
$89.00
+24.7%
+78.7%$3.27B$206.53M-56.20750
ITGR
Integer
2.2281 of 5 stars
$89.28
+0.0%
$106.00
+18.7%
+32.4%$2.95B$1.07B30.477,500Gap Up
NUVA
NuVasive
1.7445 of 5 stars
$56.54
+1.8%
$66.58
+17.8%
+6.3%$2.92B$1.05B2,828.412,700Analyst Report
News Coverage
CSII
Cardiovascular Systems
2.0481 of 5 stars
$33.52
+0.9%
$44.75
+33.5%
-10.4%$1.36B$258.97M-98.59779Short Interest ↓
ATEC
Alphatec
2.4315 of 5 stars
$12.19
+0.2%
$19.79
+62.3%
+18.6%$1.22B$144.86M-9.83296
ANGO
AngioDynamics
2.4015 of 5 stars
$27.37
+5.9%
$34.50
+26.1%
+134.6%$1.06B$291.01M-33.38800Analyst Upgrade
Gap Up
CRY
CryoLife
2.5414 of 5 stars
$21.36
+0.7%
$35.50
+66.2%
+12.1%$840.09M$253.23M-68.901,200
SRDX
Surmodics
2.4814 of 5 stars
$54.90
+1.6%
$73.00
+33.0%
+31.2%$761.57M$94.86M549.05370
OFIX
Orthofix Medical
1.7348 of 5 stars
$36.24
+0.3%
$39.00
+7.6%
+4.7%$713.75M$406.56M-86.291,036
ARAY
Accuray
1.9214 of 5 stars
$3.93
+0.3%
N/A+28.4%$357.08M$396.29M-56.14932
IVC
Invacare
1.9698 of 5 stars
$4.59
+0.2%
$9.50
+107.0%
-41.8%$160.69M$850.69M-4.253,400
RMTI
Rockwell Medical
1.7048 of 5 stars
$0.60
+3.3%
$5.00
+733.1%
-44.9%$56.35M$62.20M-1.67300Short Interest ↓
Positive News
This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.